Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors
Crossref DOI link: https://doi.org/10.1007/s13300-021-01139-2
Published Online: 2021-08-28
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Yan
Zhu, Jiankun
Wu, Haiya
Deng, Yuying
Ji, Qiuhe http://orcid.org/0000-0002-3010-5837
Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2021-08-28
Version of Record valid from 2021-08-28
Article History
Received: 30 April 2021
Accepted: 4 August 2021
First Online: 28 August 2021